Amoytop Biotech Partnership
Reached a general sub-licensing agreement with Amoytop Biotech in China to initiate preclinical drug development in January 2013.
Reached a general sub-licensing agreement with Amoytop Biotech in China to initiate preclinical drug development in January 2013.
Completed core technology licensing for HSP90 from University of Southern California in May 2012.
$100,000 SBIR grant from US Army in December 2011 to work on wound healing.